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Abstract 
Mycotoxins, toxic secondary metabolites of fungi, affect global agriculture so prolifically that they 
are virtually ubiquitous at some concentration in the average human diet. Studies of in vitro and in vivo 
toxicity are discussed, leading to investigations of co-exposed mycotoxins, as well as carcinogenic 
effects. Some of the most common and toxicologically significant mycotoxins, such as the aflatoxins, 
ochratoxins, fumonisins, trichothecenes, and zearalenone, are outlined. The wide variety of 
pathogenic mechanisms these compounds employ are shown capable of inducing a complex set of 
interactions. Of particular note are potential synergisms between mycotoxins with regard to 
carcinogenic attributable risk, indicating an important field for future study. 
Keywords: mycotoxins; carcinogenesis; mycotoxin co-exposure; mycotoxin carcinogenicity; colorectal 
cancer; hepatocellular cancer 
Introduction 
Fungi have been observed for millennia, and are found to be relatively ubiquitous in nature, with 
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spores able to travel vast distances across the surface of the planet (Hirst & Stedman 1967). Many 
important agricultural products, especially those rich in carbohydrates, are attractive colonization sites 
for fungi. Some toxic secondary metabolites of fungal growth are identified as mycotoxins, and may be 
found to contaminate  agricultural products (Chelkowski 1998). 
Many species from the Alternaria, Aspergillus, Claviceps, and Fusarium genera, as well as 
some Penicillium species, and several others are known to produce mycotoxins (Zain 2011). 
Mycotoxins are small organic molecules produced as secondary metabolites of fungal growth, 
observed as toxic to animals and humans who consume them. Mycotoxicosis is the term used for 
poisoning associated with exposures to mycotoxins. The symptoms of mycotoxicosis depend on the 
type of mycotoxin, the concentration and duration of exposure, as well as age, health, and sex of the 
exposed individual (Bennett & Klich 2003). 
Like all toxicological syndromes, mycotoxicoses can be categorized as acute or chronic. Acute 
toxicity generally has a rapid onset and an obvious toxic response, while chronic toxicity is 
characterized by low dose exposure over a long time period, resulting in cancers and other generally 
irreversible effects (Williams et al. 2015). Although the main human and veterinary health burdens of 
mycotoxin exposure are related to chronic exposure (e.g., cancer, kidney damage, immune 
suppression), the best-known mycotoxin episodes are manifestations of acute effects (e.g., Turkey X-
syndrome, human ergotism, stachybotryotoxicosis in livestock) (Bennett & Klich 2003). 
Some of the most frequently encountered mycotoxins ochratoxin A (OTA) and deoxynivalenol 
(DON), are reported to interfere with mammalian cellular processes including DNA replication and 
protein synthesis (Bensassi et al. 2009; Pfohl-Leszkowicz & Manderville 2012). Other mycotoxins, 
particularly aflatoxin B1 (AFB1) and its metabolic precursor sterigmatocystin, have been identified as 
carcinogenic by the World Health Organization's (WHO) International Agency for Research on Cancer 
(IARC) Monographs Program (International Agency for Research on Cancer 2007). The IARC 
Monographs identify environmental factors associated by scientific literature with increased risk of 
carcinogenesis in humans. 
As a result of crops affected by fungal infection being eaten, either directly by humans or as 
feed for livestock, mycotoxins are introduced to the food chain. Mycotoxins are able to resist 
decomposition or being broken down by mammalian digestion, even by ruminant livestock, allowing 
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these compounds to persist in meat and even dairy products (Kang’ethe & Lang’a 2009). This gives 
rise to certain partially metabolized mycotoxins, such as aflatoxin M1 (AFM1), present in milk from 
cows or humans that consumed feed or food contaminated by aflatoxins. Even temperature 
treatments, such as cooking and freezing, do not inactivate some mycotoxins. 
Due to the broad, overlapping habitats of fungal species, it is observed that multiple species 
may affect a given region (Alkadri et al. 2014; Jackson et al. 2012). Furthermore, one fungal species 
may produce many different mycotoxins, and the same mycotoxin may also be produced by several 
different species. Since many species are each capable of producing multiple mycotoxin compounds, 
and agricultural products from many sources may be aggregated prior to processing en masse, there 
is a very high likelihood of multiple mycotoxins co-occurring in food and feed products (Mngadi et al. 
2008). Consequently, in the richly varied modern diet, individuals undergo dietary exposure to a very 
wide variety of mycotoxins (Abia et al. 2013; Solfrizzo et al. 2014). 
Various mycotoxins were investigated since early last century for individual toxicity, usually in 
regard to acute pathologies (Schreiner & Reed 1908). However, recent research is indicating complex 
interactions between chronic co-exposure to multiple mycotoxins possibly having synergistic, or even 
mitigating effects (Bensassi et al. 2014; Grenier & Oswald 2011). Some of the most common and 
toxicologically significant mycotoxins, such as the aflatoxins, ochratoxins, fumonisins, trichothecenes, 
and zearalenone, are outlined below, followed by a description of possible health burdens caused by 
co-occurrence and co-exposure of multiple mycotoxins, as well as their carcinogenic effects.  
Mycotoxins 
Aflatoxins 
There are six predominant aflatoxins, named AFB1, aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), 
aflatoxin G2 (AFG2), AFM1, and aflatoxin M2  (AFM2) (Reddy et al. 2010). In this nomenclature, 'B' and 
'G' are used to denote compounds that fluoresce blue or green, respectively, under ultraviolet light. 
The 'M1' and 'M2' compounds are not found on cereal products themselves, but are metabolites 
expressed in milk of mammals whose diet was contaminated by aflatoxins B1 and B2, respectively 
(Garrido et al. 2003). Finally, the '2' numbered aflatoxins are structural isomers missing one double 
bond, as compared to the respective '1' numbered molecule, illustrated in figure 1 below. Among the 
Aspergillus genus, species in the section Flavi are most frequently reported producers of AFB1, while 
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A. flavus and A. parasiticus are commonly used as producers of AFB1, AFB2, AFG1 and AFG2 for 
morphological studies (Klich 2007; Varga et al. 2011).  
AFB1 is identified as the most potent naturally occurring carcinogen due to being metabolised in 
the liver to a reactive epoxide, which may form DNA adducts at some guanine residues (Gouas et al. 
2009; Bedard & Massey 2006). The epoxide adduct is reported to catalyze a G → T mutation in the 
p53 tumour suppressor protein gene, where it causes a missense mutation effectively inactivating the 
gene's protein product  (Besaratinia et al. 2009). This identified mechanism, as well as previous 
studies in animal models, has lead the IARC to classify AFB1, AFB2, AFG1, and AFG2 as Group 1 
carcinogens, denoting their explicit carcinogenicity to humans (World Health Organization & 
International Agency for Research on Cancer 2002).  Developing nations, including most of Africa, 
Latin and South Americas, and Asia are identified as high risk areas for aflatoxin exposure, leading to 
aflatoxicosis (Williams et al. 2004). 
An Italian study using lactating goats illustrated the relatively rapid absorption of AFB1 and its 
subsequent metabolism and excretion as AFM1, with peak concentrations of AFM1 detected in 
expressed milk between 3 and 6 hours after oral AFB1 administration, and non-detection of AFM1 after 
3.5 days post-dosage (Battacone et al. 2012). However, the amount of AFM1 detected only accounted 
for less than 0.2% of the original dose, leaving a large majority as either degraded or excreted by other 
mechanisms. The rates of aflatoxin absorption and degradation were shown to be affected not only by 
species, but by diet, specifically through varying the roughage component of livestock feed (Upadhaya 
et al. 2009). 
Ochratoxins 
Ochratoxin is a mycotoxin that comes in three secondary metabolite forms, A, B, and C, all of 
which are produced by Penicillium and Aspergillus species contaminating in a wide range of 
commodities including staple food crops and beverages such as beer and wine (Bayman & Baker 
2006). OTA is one of the most commonly encountered mycotoxins, and was reportedly detected in 
60% of a healthy Moroccan study population of blood donors (Filali et al. 2002). The structure of OTA 
is depicted in figure 2; the related compound ochratoxin B differs only in having hydrogen in place of 
the chlorine atom, and ochratoxin C is an ethyl ester form of OTA produced in presence of rumen fluid 
(Fuchs et al. 1984). 
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OTA has been hypothesized to cause oxidative damage to DNA, leading to mutagenesis and 
potential carcinogenesis (Zepnik 2001). Recent papers also propose direct genotoxic mechanisms for 
OTA, describing a pathway that metabolizes OTA into an electrophilic species capable of directly 
binding to some nucleotide bases (Pfohl-Leszkowicz & Manderville 2012). Consequently, OTA is 
classified as a possible human carcinogen by IARC, citing sufficient evidence of carcinogenicity in 
animal models, but insufficient evidence from human studies (World Health Organization & 
International Agency for Research on Cancer 2002). 
OTA is known to bind to blood plasma proteins, delaying its excretion in urine by up to 30 days, 
a fact greatly relevant to the development of methods for exposure detection (Kumagai 1985). Despite 
this temporary bioaccumulation, no significant relationship was found between age and plasma OTA 
levels in a British study population (Gilbert et al. 2001). However, a variable relationship between 
plasma and urine levels was hypothesized to result from decreased efficiency of OTA metabolic and 
excretion mechanisms with age. 
Fumonisins 
Since discovery of this group of mycotoxins in 1988, at least 28 compounds have been 
identified as fumonisins, with some of the most common forms illustrated in figure 3 (Voss et al. 2007; 
Bolger et al. 2001; Tamura et al. 2014). These compounds are predominantly produced on maize and 
maize products by F. proliferatum and F. verticillioides (formerly F. moniliforme), but have also been 
reported in cultures of several other Fusarium spp., as well as the Alternaria alternata f. sp. lycopersici 
natively growing on tomatoes, and Aspergillus niger on coffee and grapes (Weidenbörner 2001; Scott 
2012). Among the fumonisin compounds, fumonisin B1 (FB1) is produced most abundantly, and 
features most prominently in the literature (Mahmoodi et al. 2012). In an analysis of various foods and 
feeds from Burkina Faso, FB1 was detected in over 80% of samples, with FB2 and FB3 also found in 
69% and 46% of samples, respectively (Warth et al. 2012). 
Dietary exposure to fumonisins was reported to have rapid but low absorption, based on oral 
administration of FB1 in a rat model, with 3.5% of the dose observed in plasma, peaking in 
concentration after one hour (Voss et al. 2007). Another study in rats reported observations supporting 
a hypothesis of FB1 genotoxicity mediated by oxidative stress mechanisms (Theumer et al. 2010). 
Fusaria-derived toxins such as FB1 and FB2 are listed as possible carcinogens in Group 2B of the 
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IARC classification (World Health Organization & International Agency for Research on Cancer 2002). 
A recent etiological study also found some positive correlation between prevalence of FB1 
contamination in rice and incidence of esophageal cancer, though this relationship was not seen in 
other staple foods, such as corn, in the same region of Iran (Alizadeh et al. 2012). 
Due to a structural resemblance with ceramide, fumonisins are also reported to disrupt the de 
novo synthesis of ceramide and sphingolipid metabolism, potentially leading to broad impairment of 
cellular signalling mechanisms (Dutton 1996). FB1 neurotoxicity was also observed in a carp model 
(Kovacić et al. 2009). However, formation of fumonisin A1 (FA1) through acetylation of the amine site in 
FB1 was reported to block these effects (Stockmann-Juvala & Savolainen 2008). Additionally, types of 
maize processing that involved cooking in alkaline conditions were estimated to mitigate some 
adverse health effects through hydrolysis of the fumonisins (Voss et al. 2007). 
T-2 Toxin and HT-2 Toxin 
The T-2 and HT-2 toxins are produced by various Fusarium species, particularly F. 
sporotrichioides and F. poae, reportedly affecting several major cereal crops including oats, barley, 
corn, and wheat (Weidner et al. 2013). A European evaluation found oats and oat products contained 
the highest summed concentrations of these two contaminants (EFSA Panel on Contaminants in the 
Food Chain 2011). 
These toxins are common representatives of the type A trichothecenes, a group identified by 
specific arrangements of ligands around a sesquiterpenoid cyclic ring (Cano-Sancho et al. 2012). As 
illustrated in figure 4, HT-2 is structurally differentiated from T-2 by oxidation of an acetate ligand at C-
4. 
Exposure to these compounds is associated with diverse pathologies including skin irritation, 
gastrointestinal issues (nausea, cramping, and vomiting), impaired mitochondrial function, and 
hypotrophy of the spleen and thymus (Ueno 1984). Recent research has discovered evidence for 
these toxins crossing the blood-brain barrier in vitro, linking them to neurotoxic effects (Weidner et al. 
2013). However, the predominant human health effects reported in literature associate these toxins 
with inhibited protein synthesis and apoptosis in a wide variety of in vitro and ex vitro cells, as well as 
in vivo organs, including brain, gastrointestinal tract, skin, spleen, and thymus (Li et al. 2011; EFSA 
Panel on Contaminants in the Food Chain 2011). Though these tricothecenes were not observed to 
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produce genotoxic or directly mutagenic effects in vitro, the aforementioned widespread disruptive 
effects of exposure may potentially increase susceptibility to other carcinogenic factors (Rocha et al. 
2005). 
Deoxynivalenol 
DON is produced by F. graminearum and F. culmorum on cereal crops, and is one of the most 
commonly encountered mycotoxins (Reddy et al. 2010). Acute dietary exposure to DON is 
characterized in animals by emesis and feed refusal. DON is rapidly metabolized for urinary excretion 
as glucuronide conjugates within 24hrs of dietary exposure (Lake et al. 1987).  
As illustrated in figure 5, DON may be identified as a type-B trichothecene by the carbonyl 
group at C-8. Like all trichothecenes, DON is a strong inhibitor of protein synthesis (Ji et al. 2014). 
Literature reports DON preventing eukaryotic polypeptide assembly by interfering with activity of the 
60S ribosomal subunit (Pestka 2007). 
In 2002, an IARC review of available literature listed DON as a Group 3 (not classifiable) human 
carcinogen due to inadequate evidence of animal carcinogenicity, and lack of investigation in humans 
(World Health Organization & International Agency for Research on Cancer 2002). However, a more 
recent in vivo mouse study concluded oral exposure to DON was able to induce lung 
adenocarcinomas, with the carcinogenic effect synergized by co-exposure to sterigmatocystin (Huang 
et al. 2004). Unfortunately, the results of this study were argued to be invalid by a following review 
article, citing an inappropriate experimental design that did not represent real-world conditions of 
human exposure to DON (Ma & Guo 2008). A third study reported observing clear, dose-dependent 
induction of DNA strand breakage by DON treatment of in vitro liver cells (Zhang et al. 2009). 
Zearalenone 
Zearalenone (ZEN) is another common mycotoxin produced by various Fusarium fungi, 
detected in some 90% of sampled cereal crops that were grown in central European countries such as 
Austria, France, and Germany (Baliukoniene et al. 2003). ZEN shares a structural similarity with the 
human sex hormone 17β-estradiol, and therefore also has a similar affinity to and effect on estrogen 
receptors, resulting in associations with fertility problems in both humans and livestock (Nordic Council 
of Ministers 1998). 
9 
 
IARC found limited evidence of ZEN carcinogenicity in animal models, classifying it together 
with DON in Group 3 (World Health Organization & International Agency for Research on Cancer 
2002). Due to rapid metabolism, bioaccumulation is understood to be insignificant, though co-
exposure with other mycotoxins is estimated to present a probable health risk due to inadequately 
researched interactions (Speijers & Speijers 2004). 
Interestingly, ZEN is frequently reported to have antagonistic effects on the toxicity of some co-
exposed mycotoxins. For example, OTA-induced kidney damage in rats was observed to be 
significantly mitigated in comparison cases where the animals were given both ZEN and OTA (Grenier 
& Oswald 2011). In another study, ZEN co-exposed with DON was also observed to produce sub-
additive or antagonistic effect on levels of some serum immunoglobulins, as compared to individual 
ZEN or DON exposure cases (Forsell et al. 1986). 
Co-occurrence and co-exposure of multiple mycotoxins 
In a South African study, the co-occurrence of mycotoxin-producing fungi on crops was reported 
for almost half of contaminated samples (Mngadi et al. 2008). As mentioned before, many species of 
mycotoxin-producing fungi are known to be capable of producing more than one mycotoxin. A Polish 
study reported co-occurrence of mycotoxins in over half the rye samples analysed, with the most 
common combination being DON and ZEN (Błajet-Kosicka et al. 2014). This mycotoxin pair was also 
detected in a study on several Chinese wheat producing regions (Ji et al. 2014). Further, analysis of a 
variety of foods and feeds produced in Burkina Faso and Mozambique reported up to 28 different 
mycotoxins present and quantifiable in a single sample (Warth et al. 2012). Finally, even greater co-
occurrence was reported after a recent analysis detecting between 5 and 41 of the previously 
discussed mycotoxins in individual samples of maize from various agricultural sites in Malawi 
(Matumba et al. 2014). 
Government and industry regulations exist to minimize the concentrations of individual 
mycotoxins allowed into food and feed products (Zain 2011; The Commission of the European 
Communities 2006). However, these regulations are based on individual toxicities, and as such, do not 
take into account the complex dynamics of compounded risk from co-exposure to groups of 
mycotoxins, for even acute pathologies. Agricultural products are effectively aggregated and 
heterogeneously distributed for consumer convenience, leading to a highly unpredictable mixture of 
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possible mycotoxin contamination in food products (Turner et al. 2012). An analysis of 174 cereal-
based food products from Belgian supermarkets reported a median of four mycotoxins present in 
these consumer-available products (De Boevre et al. 2012). Population studies of mycotoxin exposure 
therefore also frequently report detectable amounts of multiple mycotoxins in blood and urine samples 
from human populations all over the globe (Abia et al. 2013; Solfrizzo et al. 2014; Shirima et al. 2014; 
Njumbe-Ediage et al. 2012). Consequently, an important question remains posed by the current 
literature, to identify the chronic risks associated with repetitive exposure to low levels of multiple 
mycotoxins (Warth et al. 2013). 
Several in vivo studies with various species of farm animals co-exposed to pairs of mycotoxins 
were compared in the literature, illustrating a complex set of possible synergistic, additive, sub-
additive, or antagonistic effects on animal health and growth metrics, as compared with single 
mycotoxin exposures (Grenier & Oswald 2011; Speijers & Speijers 2004; Bensassi et al. 2014). These 
reports serve to highlight not only the complex and dynamic interaction between co-exposures, but 
also the great variety of possible co-exposure situations, and the dearth of studies representative of 
the real-world situation, particularly in humans (Streit et al. 2013). 
Mycotoxins and carcinogenesis 
Although mycotoxin exposure has been associated with several acute and chronic human 
health effects, one of the most important health burdens associated with mycotoxin exposure is the 
development of cancers. The possible causes of carcinogenesis are virtually innumerable, however, 
exposure to some chemical factors (e.g., (multi-)mycotoxin exposure) is known to be a strong 
modulator of carcinogenic risk (Cohen & Arnold 2011). In the unfortunate case of such exposures, 
three stages are identified in the carcinogenic process: initiation, promotion, and progression (Oliveira 
et al. 2007). For example, AFB1 is known to be a potent initiator of hepatocellular carcinoma, while 
fumonisins are reported to be strong tumour promoters after initiation of carcinogenesis by another 
agent, such as AFB1 (Riley 1998). Although several cancers might be associated with multi-mycotoxin 
exposure (e.g. liver, colon, rectum, esophageal, breast cancer, etc.), direct evidence is still scarce for 
most of these cancer types, and multi-mycotoxin exposure may not yet have been investigated for 
causal relationship. Therefore, only the two most frequently studied cancer types in relation to 
mycotoxin exposure will be outlined in this review paper, namely colorectal and hepatocellular 
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carcinoma. 
Colorectal carcinoma 
Cancers of either the colon or rectum are the fourth most common causes of death by cancer 
worldwide (World Health Organization 2014). Rates of incidence rank colorectal cancer slightly higher, 
as the second and third most common site of cancer diagnosis in women and men, respectively 
(EpiCast Reports 2012). As with all cancers, the risk of incidence increases with age (Howlader et al. 
2011). This is largely due to cumulative risk of carcinogenesis over the course of chronic exposure to 
potential carcinogens. Particularly, since the prevalent vector of human exposure to mycotoxins is 
through the diet, it is postulated that the colorectal region is itself highly exposed to these compounds, 
and therefore a prominent target for pathological developments (Pfohl-Leszkowicz et al. 1995; Bouhet 
& Oswald 2005). 
The HT-29 human colonic cell line was used for in vitro studies of DON and FB1, both of which 
were observed to induce apoptosis, though by different mechanisms (Schmelz et al. 1998; Ma et al. 
2012). DON-induced apoptosis was separately reported to be caused by mitochondrial dysfunction, 
while treatment with FB1 resulted in accumulation of endogenous free sphingoid bases, inhibiting 
growth and inducing apoptosis. A different colonic cell line, HCT-116, was used in an investigation of 
AFB1, reporting induction of DNA damage and lesions, as well as inactivation of the ATR/Chk1 
pathway that would normally help address an appropriate response to this damage (Gursoy-Yuzugullu 
et al. 2011). Further investigation of synergistic interactions between co-exposed mycotoxins is 
especially required in the colorectal context. 
Hepatocellular carcinoma 
Almost 700,000 individuals were recorded to have died of liver cancer in 2008, increasing to 
over 750,000 by 2010, making hepatocellular carcinoma the third most deadly form of cancer 
worldwide (Lozano et al. 2012; Ferlay et al. 2010). A slightly older report estimates the annual global 
diagnosis rate at over 560,000 individuals in 2000, though such estimates are reported elsewhere to 
experience growth at a rate of at least 3% annually (Bosch et al. 2004; Howlader et al. 2011). 
There is a strong, established link between aflatoxin exposure and development of malignant 
hepatomas, with a speculated 5% to 28% of cases actually caused by aflatoxins (Gursoy-Yuzugullu et 
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al. 2011). The associated mechanism, as previously discussed, involves metabolism of AFB1 in the 
liver to a highly reactive species capable of forming mutagenic DNA adducts. One well-known mutation 
results in the inactivation of p53 tumour suppressor gene, enabling initiation of carcinogenesis. 
Subsequently, a synergistic effect promoting tumour growth in the liver was reported for co-exposure 
to fumonisins (Carlson et al. 2001). Less pronounced effects were reported by multiple studies on co-
exposed OTA also resulting in increased hepatic lipid levels and increased relative weight of the organ 
(Grenier & Oswald 2011). 
Conclusion 
Though literally innumerable fungal secondary metabolites exist, a few were identified as 
particularly harmful by centuries of experience and research. The acute and chronic health effects of 
exposure to these xenobiotics vary almost as widely as the mechanisms by which various mycotoxins 
produce these effects. Nevertheless, great efforts of research have helped in characterizing the 
hazards of mycotoxins. Unfortunately, the rate at which mycotoxins are produced and the ubiquity of 
their production throughout the world’s agricultural industries, coupled with modern food processing 
and distribution techniques, indicates a deeper understanding of actual exposure is needed. In 
particular, both co-exposure and chronic exposure are increasingly identified as real-world factors, 
consequences of which are most relevant to inquiries regarding real-world health effects. 
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